Adam R. Craig
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 13
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 15
- Acute Myeloid Leukemia Research 3
- Rheumatology top 5%
- Eosinophilic Disorders and Syndromes 9
-
- Cancer therapeutics and mechanisms 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Jörge E. CortesHagop M. KantarjianTessa L. HolyoakeAndreas HochhausHeather G. JørgensenRaghunadharao DigumartiElaine AllanFranck E. Nicolini
- Cited by
- GeneticsHematologyRheumatology
- Partner nations
- United StatesFranceGermany
In The Last Decade
Adam R. Craig
23 papers receiving 492 citations
Peers
Comparison fields: 5 of 44
- Genetics 363
- Hematology 380
- Rheumatology 167
- Toxicology 17
- Oncology 62
Countries citing papers authored by Adam R. Craig
This map shows the geographic impact of Adam R. Craig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam R. Craig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam R. Craig more than expected).
Fields of papers citing papers by Adam R. Craig
This network shows the impact of papers produced by Adam R. Craig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam R. Craig. The network helps show where Adam R. Craig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam R. Craig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 39 | |
| 2 | 2022 | 7 | |
| 3 | 2021 | 34 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 3 | |
| 6 | 2015 | 22 | |
| 7 | 2015 | 10 | |
| 8 | 2015 | 5 | |
| 9 | 2014 | 24 | |
| 10 | 2013 | 52 | |
| 11 | 2012 | 89 | |
| 12 | 2011 | 61 | |
| 13 | 2009 | 3 | |
| 14 | 2009 | 28 | |
| 15 | 2009 | 3 | |
| 16 | 2009 | 32 | |
| 17 | 2007 | 20 | |
| 18 | 2007 | 11 | |
| 19 | 2006 | 1 | |
| 20 | 2005 | 21 |
About Adam R. Craig
Adam R. Craig is a scholar working on Genetics, Hematology and Rheumatology, having authored 23 papers that have together received 498 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Eosinophilic Disorders and Syndromes (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (3 papers), Cancer therapeutics and mechanisms (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Genetics (363 citations), Hematology (380 citations) and Rheumatology (167 citations). Adam R. Craig has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Jörge E. Cortes, Hagop M. Kantarjian, Tessa L. Holyoake, Andreas Hochhaus, Heather G. Jørgensen, Raghunadharao Digumarti, Elaine Allan, Franck E. Nicolini, Dan Jones and Delphine Réa. Their work appears in journals such as Journal of Clinical Oncology, Blood and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.